BSEC to probe share price hike of 2 pharma companies | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Saturday
June 14, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SATURDAY, JUNE 14, 2025
BSEC to probe share price hike of 2 pharma companies

Stocks

TBS Report
16 July, 2020, 08:20 pm
Last modified: 16 July, 2020, 08:25 pm

Related News

  • Gold price goes up by Tk2,415 per bhori ahead of Eid
  • Tk2.52cr fines levied by BSEC for securities law breaches in May
  • Berger Paints rights share subscription starts 15 July
  • Berger Paints gets BSEC approval to issue rights shares
  • BSEC slashes BO account fee by Tk300

BSEC to probe share price hike of 2 pharma companies

The committee will submit the investigation report within the next 30 working days

TBS Report
16 July, 2020, 08:20 pm
Last modified: 16 July, 2020, 08:25 pm
BSEC to probe share price hike of 2 pharma companies

The Bangladesh Securities and Exchange Commission (BSEC) has formed an inquiry committee to investigate the unusual price hike of the shares of two pharmaceutical companies - Central Pharmaceuticals Ltd and Beacon Pharmaceuticals Ltd.

An official of the securities regulator told The Business Standard that the committee will investigate the unusual movements of both - share prices and volumes - of the listed companies.

"Shamsur Rahman, deputy director and Sultan Salauddin, assistant director of the BSEC are the two members of the committee," he added.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The committee will submit the investigation report within the next 30 working days.

Central Pharmaceuticals Ltd

In February this year, the company's share price suddenly jumped by 98 percent to Tk17 at the Dhaka Stock Exchange (DSE). However, in March, its share price fell by 41 percent.

In this regard, DSE had sent a notice to Central Pharma asking the reason for its unusual increase in share price. But the company replied that there was no price sensitive information for such an increase.

The Business Standard did a report on this unusual price hike.

The closing price of each Central Pharma share was Tk12.40 on Thursday at the DSE.

The company's board of directors jointly hold 25.89 percent shares which should be at least 30 percent as per law, according to industry sources.

The net profit of Central Pharmaceuticals Ltd dropped 64 percent to Tk5 crore in the last four years.

In the third quarter of the 2019-20 financial year, the company posted loss per share of Tk0.18.

In the 2018-19 financial year, Central Pharma paid only 1 percent cash dividend to its shareholders.

Beacon Pharmaceuticals Ltd

The share price of Beacon Pharmaceuticals Ltd increased by 271 percent to Tk74.20 in the last nine months.

The company also replied to the DSE notice saying that there was no price sensitive information for its share price hike.

In the third quarter of the last financial year, Beacon Pharma posted earnings per share of Tk0.55.

It paid 5 percent cash dividend to its shareholders in the 2018-19 financial year.

Economy / Top News

BSEC / Pharma / price hike / Share

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Security personnel react at an impact site following a missile attack from Iran on Israel, in Tel Aviv, Israel, June 13. REUTERS/Itay Cohen
    Over 80 killed on both sides as Iran, Israel continue missile strikes
  • Vehicles were seen stuck on the Dhaka-Tangail-Jamuna Bridge highway due to a traffic jam stretching 15 kilometres on 14 June 2025. Photo: TBS
    15km traffic jam on Dhaka-Tangail-Jamuna Bridge highway as post-Eid rush continues
  • Illustration: TBS
    From Greta Thunberg's book to an exquisite pen: What Tarique gifted CA Yunus

MOST VIEWED

  • Energy adviser Fouzul Kabir Khan with other government officials during a visit to Sylhet gas field on 13 June 2025. Photo: TBS
    I would disconnect gas supply to every home in Dhaka if I could: Energy adviser
  • BNP Acting Chairperson Tarique Rahman and Chief Adviser  Muhammad Yunus meet at Dorchester Hotel in London, UK on 13 June 2025. Photo: CA Press Wing
    National polls possible in 2nd week of February, agree Yunus, Tarique in 'historic' London meeting
  • Rescuers work at the scene of a damaged building in the aftermath of Israeli strikes, in Tehran, Iran, June 13, 2025. Majid Asgaripour/WANA (West Asia News Agency) via REUTERS
    Tehran retaliates with 100 drones after Israel strikes Iran's nuclear facilities, kills military leaders
  • From fact-checker to fact-checked: CA Press Wing’s turn in the hot seat
    From fact-checker to fact-checked: CA Press Wing’s turn in the hot seat
  • UK Prime Minister Keir Starmer, Chief Adviser Muhammad Yunus
    Disclosure of unconfirmed Yunus-Starmer meeting shows ‘diplomatic imprudence’: Analysts
  • Flight AI 379 had landed. File Photo: Hindustan Times
    Day after Ahmedabad crash, Air India flight makes emergency landing in Thailand after bomb threat

Related News

  • Gold price goes up by Tk2,415 per bhori ahead of Eid
  • Tk2.52cr fines levied by BSEC for securities law breaches in May
  • Berger Paints rights share subscription starts 15 July
  • Berger Paints gets BSEC approval to issue rights shares
  • BSEC slashes BO account fee by Tk300

Features

Photos: Collected

Kurtis that make a great office wear

22h | Mode
Among pet birds in the country, lovebirds are the most common, and they are also the most numerous in the haat. Photo: Junayet Rashel

Where feathers meet fortune: How a small pigeon stall became Dhaka’s premiere bird market

2d | Panorama
Illustration: Duniya Jahan/ TBS

Forget Katy Perry, here’s Bangladesh’s Ruthba Yasmin shooting for the moon

3d | Features
File photo of Eid holidaymakers returning to the capital from their country homes/Rajib Dhar

Dhaka: The city we never want to return to, but always do

5d | Features

More Videos from TBS

Tehran-Tel Aviv devastated by counterattacks

Tehran-Tel Aviv devastated by counterattacks

8m | TBS World
How ready is the new IRGC chief to give a befitting reply to Israel?

How ready is the new IRGC chief to give a befitting reply to Israel?

53m | TBS World
Iran says nuclear talks with US ‘meaningless’ after Israel attack

Iran says nuclear talks with US ‘meaningless’ after Israel attack

1h | TBS News Updates
CA Yunus returns home from London

CA Yunus returns home from London

2h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net